All Updates

All Updates

icon
Filter
Regulation/policy
FDA approval
Solar Foods obtains self-affirmed GRAS status for Solein in US
Plant-based Meat
Sep 2, 2024
This week:
Management news
6K Additive awarded project to develop C-103 powder for additive manufacturing
Additive Manufacturing
Sep 27, 2024
Partnerships
WAAM3D partners with Innovative Space Carrier, Cranfield University, and Aichi Sangyo for space transport development
Additive Manufacturing
Sep 19, 2024
Product updates
Akselos introduces software for FPSO monitoring
Digital Twin
Yesterday
Partnerships
Routable partners with Convera to expand global payment capabilities for businesses
Business Expense Management
Yesterday
Product updates
Lenovo launches AI services to improve AI accessibility for any enterprise
Generative AI Infrastructure
Yesterday
Product updates
Guesty launches AI-powered website builder and review analysis tool to enhance product offering
Travel Tech
Yesterday
Product updates
Cloudera introduces new accelerators for ML project deployment
Machine Learning Infrastructure
Yesterday
Funding
Operant AI raises USD 10 million in Series A funding to boost runtime protection
Next-gen Cybersecurity
Yesterday
Funding
Aembit raises USD 25 million in Series A funding to advance IAM solutions
Identity & Access Management
Yesterday
Product updates
Saviynt launches Intelligence Suite for identity security
Identity & Access Management
Yesterday
Plant-based Meat

Plant-based Meat

Sep 2, 2024

Solar Foods obtains self-affirmed GRAS status for Solein in US

Regulation/policy
FDA approval

  • Solar Foods, an alternative protein ingredient startup, has obtained self-affirmed Generally Recognized as Safe (GRAS) status in the US for its Solein protein ingredient, marking a significant step toward its commercialization and entry into the US market.

  • The next steps for Solar Foods include registering its production facility with the FDA, starting food exports to the US, and aiming to obtain "notified" GRAS status by receiving a "No Questions Letter" from the FDA by the end of 2026.

  • Solar Foods has also filed for novel food regulatory approvals for Solein in the UK and the EU and sees the US GRAS status as potentially contributing to expansion into other markets without specific novel food approvals, such as Japan.

  • Analyst QuickTake: Solar Foods has had an active year, marked by significant developments such as the launching of the world’s first air protein factory, securing USD 8.6 million in Series B funding, and launching products through its partnership with Ajinomoto. The GRAS status will further validate the safety of Solein, which has already demonstrated its commercial viability in the Singaporean market.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.